课题基金 / 基金详情

项目摘要

项目成果

Katherine L. Knight的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Microbiota are required for the development of secondary lymphoid tissues, including gut- associated lymphoid tissues (GALT). Interactions between GALT and the microbiota are especially important in rabbits, as B cells proliferate and mutate their V(D)J genes in response to select commensal bacteria. Further, VHa B cells, identified because they utilize VH1, are selectively expanded in GALT as a result of specific commensal bacteria. In contrast, other B cells, designated VHn, do not expand in GALT. VHa and VHn B cells differ primarily in the external surface of framework regions (FR) 1 and 3, and we propose that VHa-specific amino acids on the external surfaces of FR1 and FR3 form a binding motif that together with TLR signaling through MyD88, mediates selective expansion of VHa B cells by binding bacterial cell surface molecules. We hypothesize that this innate-like, non-antigen-specific stimulation through the B cell receptor (BCR) facilitates selective expansion of VHa B cells and diversification of the primary Ab repertoire. In Aim 1, we will test this hypothesis by identifying bacteria in GALT that selectively bind to and activate VHa but not VHn B cells. Aim 2 will test if the identified bacteria specifically drive expansion of VHa B cells in vivo; and in Aim 3, we will explore the mechanism by which the bacteria stimulate VHa B cells. The results will elucidate a new mechanism by which bacteria interact with B cells to promote development of the immune system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a mucosal vaccine to prevent Clostridium difficile infection using papilloma pseudovirus as a vector.
  • 批准号:
    10213890
  • 项目类别:
  • 资助金额:
    $50.23万
  • 财政年份:
    2020
  • 负责人:
    Katherine L. Knight
  • 依托单位:
Prevention of GVHD by a probiotic exopolysaccharide.
  • 批准号:
    10081555
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2020
  • 负责人:
    Katherine L. Knight
  • 依托单位:
Microbe-driven Development of GALT
  • 批准号:
    10399453
  • 项目类别:
  • 资助金额:
    $46.18万
  • 财政年份:
    2018
  • 负责人:
    Katherine L. Knight
  • 依托单位:
Commensal Exopolysaccharide Protection from Inflammation
  • 批准号:
    8888736
  • 项目类别:
  • 资助金额:
    $20.06万
  • 财政年份:
    2015
  • 负责人:
    Katherine L. Knight
  • 依托单位:
海外基金